Hyperbaric oxygen therapy devices sales will expand through 2036, with mono-place HBOT devices at 61.1% of the product category and wound healing at 41.2% of application demand in 2026. The market was valued at USD 3.8 billion in 2025 and is forecast to record a 5.2% CAGR between 2026 and 2036.